Related references
Note: Only part of the references are listed.Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
Ahmet Dirican et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2012)
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Richard A. Adams et al.
LANCET ONCOLOGY (2011)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data
SD Walter
STATISTICS IN MEDICINE (2002)
Share Paper
